2
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other
16
Genitourinary
12
Gastrointestinal
12
Lymphoid
6
Other hematologic neoplasm
5
Breast
5
CNS
3
Head & Neck
2
Sarcoma
1
Endocrine
1
Conditions
Neuroendocrine Tumors
532
Pituitary Neoplasms
188
Multiple Endocrine Neoplasia Type 1
187
Thyroid Cancer, Papillary
178
Pheochromocytoma
153
Carcinoma, Neuroendocrine
140
Thyroid Neoplasms
130
Neoplasms
107
Paraganglioma
99
Carcinoid Tumor
99
Adrenocortical Carcinoma
92
Thyroid Carcinoma, Anaplastic
82
Pancreatic Neoplasms
69
Neoplasm Metastasis
67
Insulinoma
61
Adrenal Gland Neoplasms
61
Carcinoma, Medullary
59
Gastro-enteropancreatic neuroendocrine tumor
58
Adenocarcinoma, Follicular
58
Carcinoma, Non-Small-Cell Lung
57
Breast Neoplasms
56
Adenoma, Islet Cell
56
Lung Neoplasms
50
Sarcoma
49
Colorectal Neoplasms
49
Carcinoma, Renal Cell
49
Melanoma
47
Small Cell Lung Carcinoma
45
Prostatic Neoplasms
44
Head and Neck Neoplasms
43
Interventions
Human Growth Hormone
1
Growth Hormone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Metabolic Syndrome
×
Endocrine
×
Clear all
NCT00462475
2007-10-16
5yrGH
Federico II University
Completed
20 enrolled